You now have access to the webinar AI-Driven Insights from Real-World Data, where experts discuss how artificial intelligence applied to real-world data can help accelerate the identification, diagnosis, and treatment of undiagnosed patients. We explore a specific case study in which Volv Global, in collaboration with Takeda, Cleveland Clinic, and Komodo, applied AI-driven insights from real-world data (RWD) to rapidly identify previously undiagnosed alpha-1 antitrypsin deficiency (AATD) patients enabling earlier diagnosis, more equitable care, and personalised interventions at scale.
You can watch the full webinar below:
You will also receive the webinar link by email for future access.
If you have any questions, feel free to contact us at feedback@volv.global.
